HomeHeadlinesAmgen Inc. (AMGN) Q1 2026 (USD): Adj. EPS 5.15 (exp. 4.77), Revenue 8.62bln (exp. 8.58bln)APRIL 30, 2026 AT 08:01 PMAmgen Inc. (AMGN) Q1 2026 (USD): Adj. EPS 5.15 (exp. 4.77), Revenue 8.62bln (exp. 8.58bln)ByNewsquawk StaffImportanceLevel 1Outlook FY adj. EPS 21.70-23.10 (exp. 22.33). FY revenue 37.1-38.5bln (exp. 37.8bln). #UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#AMGEN INC#AMGN.US#FOREX#EQUITIES#METALS#US SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#AMGN#DXY#US EQUITIESExternal
APRIL 30, 2026 AT 08:01 PMAmgen Inc. (AMGN) Q1 2026 (USD): Adj. EPS 5.15 (exp. 4.77), Revenue 8.62bln (exp. 8.58bln)ByNewsquawk StaffImportanceLevel 1Outlook FY adj. EPS 21.70-23.10 (exp. 22.33). FY revenue 37.1-38.5bln (exp. 37.8bln). #UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#AMGEN INC#AMGN.US#FOREX#EQUITIES#METALS#US SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#AMGN#DXY#US EQUITIESExternal